Palvella Therapeutics (PVLA) Amortizatization of Intangibles (2019 - 2026)

Palvella Therapeutics (PVLA) reported Amortizatization of Intangibles of $15000.0 for Q1 2026, up 165.22% quarter-over-quarter from -$23000.0 in Q2 2021.

Palvella Therapeutics (PVLA) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends

Palvella Therapeutics (PVLA) has 4 years of Amortizatization of Intangibles data on file, last reported at $15000.0 in Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at $15000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$33000.0 (up 74.42% YoY), and the FY2021 annual result was -$91000.0, up 50.54% from the prior year.
  • Amortizatization of Intangibles advanced to $15000.0 in Q1 2026 per PVLA's latest filing, from -$23000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $15000.0 in Q1 2026 and troughed at $15000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 13,267.00
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -
10 Palvella Therapeutics 1.42 Bn 1.16 Bn - 15,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 15,000.00
Mar 31, 2026 15,000.00
Jun 30, 2021 -23,000.00
Jun 30, 2021 -23,000.00
Mar 31, 2021 -25,000.00
Mar 31, 2021 -25,000.00
Dec 31, 2020 -81,000.00
Dec 31, 2020 -81,000.00
Sep 30, 2020 -259,000.00
Sep 30, 2020 -259,000.00
Jun 30, 2020 -43,000.00
Jun 30, 2020 -43,000.00
Mar 31, 2020 199,000.00
Mar 31, 2020 199,000.00
Dec 31, 2019 93,000.00
Dec 31, 2019 93,000.00
Sep 30, 2019 100,000.00
Sep 30, 2019 100,000.00
Jun 30, 2019 215,000.00
Jun 30, 2019 215,000.00